Breathing Should Be Easy

We're developing a novel inhaled therapy to treat respiratory disease

1 in 10 people have asthma costing $90 billion annually in the US

33 million worldwide suffer from inadequately controlled asthma1,2

COPD recognized by WHO as third leading cause of death worldwide

In asthma and COPD, smooth muscle tightening, excess mucus production, inflammation and infections all contribute to airway narrowing

Normal Airways are unobstructed and support easy breathing

How We are Simplifying Respiratory Health

By focusing on the ROOT CAUSES OF DISEASE - knowing how to SHUT IT DOWN - and empowering patients to TAKE CONTROL
Learn More